Recent developments in the field of diabetes treatment have introduced a new class of medications known as GLP-1 receptor agonists. These agents work by mimicking the effects of glucagon-like peptide-1 (GLP-1), a https://sahilnxag473755.blogproducer.com/48347715/novel-glp-1-receptor-agonists-semaglutide-tirzepatide-and-retatrutide